Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 12620
TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715317(US20250026750, Compound 4)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715318(US20250026750, Compound 6)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715315(US20250026750, Compound 1)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715316(US20250026750, Compound 3)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715325(US20250026750, Compound 17)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715326(US20250026750, Compound 19-A)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715323(US20250026750, Compound 15-A)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715324(US20250026750, Compound 16-A)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715321(US20250026750, Compound 13)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715322(US20250026750, Compound 14-A)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715319(US20250026750, Compound 10-A)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715320(US20250026750, Compound 10-B)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715329(US20250026750, Compound 24)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715330(US20250026750, Compound 25)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715327(US20250026750, Compound 20)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Chia Tai Tianqing Pharmaceutical Group Co.

US Patent
LigandPNGBDBM715328(US20250026750, Compound 23)
Affinity DataIC50: 50nMAssay Description:A 50 ng/μL ATR stock solution was diluted with a kinase buffer (50 mM HEPES, 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, 0.01% Tween 20), and 6 μL of 1.67×, 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent